Doxycycline Hyclate NDC 62332-482

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-482Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0482Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-482-31	62332048231	100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-31)Marketed from Jan 4, 2022
62332-482-60	62332048260	60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-60)Marketed from Jan 4, 2022
62332-482-91	62332048291	1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-91)Marketed from Jan 4, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 100 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213075
Marketing start: Jan 4, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 62332-482_79225960-dfaf-43a0-8698-9c83ee345ea6SPL ID 79225960-dfaf-43a0-8698-9c83ee345ea6SPL set ID 3ae4ca12-be39-46b9-bc4c-f8356776c175RxCUI 406524, 434018, 799048, 1423080UNII 19XTS3T51UUPC 0362332483600, 0362332481606, 0362332482603
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332048231 followed by a unit qualifier and the quantity

Package 62332-0482-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 28, 2026.

Indications (excerpt from the label)

Doxycycline hyclate delayed-release tablets are a tetracycline-class drug indicated for: • Rickettsial infections (1.1) • Sexually transmitted infections (1.2) • Respiratory tract infections (1.3) • Specific bacterial infections (1.4) • Ophthalmic infections (1.5) • Anthrax, including inhalational anthrax (post-exposure) (1.6) • Alternative treatment for selected infections when penicillin is contraindicated (1.7) • Adjunctive therapy in acute intestinal amebiasis and severe acne (1.8) • Prophylaxis of malaria (1.9) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate delayed-releas…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213075

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213075
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 200 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-484
Doxycycline Hyclate	Doxycycline hyclate 75 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-481
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-482
Doxycycline Hyclate	Doxycycline hyclate 150 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-483
Doxycycline Hyclate	Doxycycline hyclate 75 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Inc.	62332-481
Doxycycline Hyclate	Doxycycline hyclate 150 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Inc.	62332-483
Doxycycline Hyclate	Doxycycline hyclate 200 mg/1	Tablet, Delayed releaseOral	Alembic Pharmaceuticals Inc.	62332-484